Vidya Wires

These high-growth small-cap companies are emerging as strong market performers in FY27 so far

Vidya Wires share price rose over 12% after a flat debut, reaching ₹ 58.48 on BSE. The IPO was oversubscribed 26.59 times, and the company plans to use proceeds for capital expenditures and debt settlement. Analysts suggest holding the stock for medium to long-term gains.

The primary market is active with six IPOs, including notable ones like Corona Remedies and Wakefit Innovations. Meesho, Aequs, and Vidya Wires made successful debuts. Nephrocare and Park Medi World are set to launch, while grey market premiums show varied trends for existing IPOs.

Vidya Wires made a flat debut on December 10, listing at ₹ 52 on NSE and ₹ 52.13 on BSE. The IPO, which received strong subscription, raised ₹ 300.01 crore. Proceeds will fund capital expenditure and repay borrowings.

Vidya Wires IPO listing date is today, December 10, and the equity shares will be listed on BSE and NSE. Ahead of the share debut, Vidya Wires IPO GMP today and experts signal that the estimated listing price would at a modest premium to the issue price.

Among mainboard IPOs, the market will witness the opening of Wakefit Innovations IPO, ICICI Prudential Asset Management Company IPO, and Corona Remedies IPO in the IPO pipeline to open in the coming week.

Vidya Wires' IPO attracted significant interest, with the allotment finalized on December 8, 2025. Successful bidders will receive shares on December 9, while refunds for unsuccessful applicants will also be processed the same day. The company's market debut is set for December 10 on NSE and BSE.

Vidya Wires IPO saw a subscription rate of 28.53 times, with strong demand from non-institutional investors. The IPO, priced between ₹ 48-52, raised ₹ 300 crore. Allotment is expected on December 08, and shares may list at ₹ 56 based on current grey market premium.